Journal article · 2026

Lessons from recent investigator-initiated trials of gene-editing therapies in China

Li Du, Kalina Kamenova, Zhangyu Wang, Meng Wang, Yujuan Li, Ruipeng Lei, Xi Zhang

Nature Medicine · Published 11 November 2026 · DOI 10.1038/s41591-026-04768-x

View at the publisherCite this paper

In brief

“Lessons from recent investigator-initiated trials of gene-editing therapies in China” is a 2026 journal article by Li Du and 6 co-authors, published in Nature Medicine. OpenAlex counts 0 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
8
Authors
7

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Du, L., Kamenova, K., Wang, Z., Wang, M., Li, Y., Lei, R., & Zhang, X. (2026). Lessons from recent investigator-initiated trials of gene-editing therapies in China. Nature Medicine. https://doi.org/10.1038/s41591-026-04768-x

MLA 9

Du, Li, et al. “Lessons from recent investigator-initiated trials of gene-editing therapies in China.” Nature Medicine, 2026. https://doi.org/10.1038/s41591-026-04768-x.

Chicago

Du, Li, Kalina Kamenova, Zhangyu Wang, Meng Wang, Yujuan Li, Ruipeng Lei, and Xi Zhang. 2026. “Lessons from recent investigator-initiated trials of gene-editing therapies in China.” Nature Medicine. https://doi.org/10.1038/s41591-026-04768-x.

Harvard

Du, L. et al. (2026) ‘Lessons from recent investigator-initiated trials of gene-editing therapies in China’, Nature Medicine. doi:10.1038/s41591-026-04768-x.

IEEE

L. Du et al., “Lessons from recent investigator-initiated trials of gene-editing therapies in China,” Nature Medicine, 2026, doi: 10.1038/s41591-026-04768-x.

BibTeX

@article{du2026lessons,
  title     = {{Lessons from recent investigator-initiated trials of gene-editing therapies in China}},
  author    = {Du, Li and Kamenova, Kalina and Wang, Zhangyu and Wang, Meng and Li, Yujuan and Lei, Ruipeng and Zhang, Xi},
  journal   = {Nature Medicine},
  year      = {2026},
  doi       = {10.1038/s41591-026-04768-x},
  url       = {https://doi.org/10.1038/s41591-026-04768-x}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation

  • gene editing therapy
  • cell and gene therapy
  • investigator-initiated trials
  • clinical trial safety
  • regulatory oversight
  • clinical supervision
  • research governance

Work with this paper

Most-cited papers in Nursing

All highly cited Nursing papers

Questions about this paper

How do I cite this paper in APA style?

Du, L., Kamenova, K., Wang, Z., Wang, M., Li, Y., Lei, R., & Zhang, X. (2026). Lessons from recent investigator-initiated trials of gene-editing therapies in China. Nature Medicine. https://doi.org/10.1038/s41591-026-04768-x

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Li Du, Kalina Kamenova, Zhangyu Wang, Meng Wang, Yujuan Li, Ruipeng Lei, Xi Zhang.

What is the DOI of this paper?

10.1038/s41591-026-04768-x, permanently at https://doi.org/10.1038/s41591-026-04768-x. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.